Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NeuroVive Pharmaceutical AB Interim report January - March 2017

Broadened project portfolioBusiness operations Significant events January-March 2017 • Strong inhibitory effects demonstrated in human hepatocellular carcinoma cells and in an experimental model of liver cancer with the Company’s new generation of sanglifehrin-based compounds in the NVP024 project. • The business operations of the Taiwanese subsidiary were sold to the Taiwanese shareholders in order to reallocate research resources to the Parent Company. • Collaboration agreement signed with a prestigious US research team in mitochondrial medicine for the NVP015 project focused

Addnode Group acquires software company Canella and strengthens its position in welfare and pharmacy solutions

Stockholm, May 18, 2017. Addnode Group has acquired the Swedish software company Canella, which develops solutions for the Nordic pharmacy and welfare market. The company had net sales of SEK 19 M in 2016.Canella delivers solutions based on the proprietary software Candos to pharmacists and county councils. Candos is approved by the Swedish eHealth Agency and is well integrated with systems used in pharmacy and healthcare. "I see very nice development opportunities with the acquisition of Canella. We acquire unique pharmaceutical skills and a modern software that will strengthen our

Interim report for the first quarter 2017: Strong start to the year creates good conditions for the future

Interim report for the period 1 January – 31 March 2017All amounts in the report relate to the Group and are stated in SEK thousands unless otherwise indicated. Figures in brackets refer to the corresponding period in the previous year.  First quarter · Revenue amounted to SEK 40,964 (4,048) thousand, an increase of 912%. · Operating profit before depreciation (EBITDA) was SEK 25,042 (-584) thousand. · Operating profit (EBIT) was SEK 24,797 (-721) thousand. Significant events after the first quarter · SEK 8,999,995.50 of the convertible debenture has been converted

IES Nomination Committee ahead of Annual General Meeting 2017

The Nomination Committee of Internationella Engelska Skolan i Sverige Holdings II AB (“Internationella Engelska Skolan” or “IES”) consists of representatives of the three main shareholders included in the company’s shareholder register as of 30 April 2017. The main purpose and responsibility of the Nomination Committee is to present proposals for the election and remuneration of the Chairman and the Board of Directors as well as the Auditors to the Annual General Meeting 2017. On 30 April 2017, the three largest shareholders of Internationella Engelska Skolan were IES Holdings I (71.2%

A quarter of growth and consolidation

First quarter: January-March 2017 · Operating revenue amounted to SEK 1,649 M (1,471), an increase of 12% or SEK 178 M. · Operating profit was SEK 66 M (41 incl. SEK -38 M in IPO costs).   · Net profit after tax for the period was SEK 40 M (-16). · Earnings per share for the period before and after dilution were SEK 0.76 (-0.82). · Operating cash flow was SEK -16 M (29). Events during the first quarter and after the end of the period · There are no significant events to report for the first quarter or after the end of the quarter.  Presentation of report today at

Internationella Engelska Skolan - Interim Report (1 July - 31 March 2016/2017)

Progress of operations in quarter 3 (January-March) · Total operating income was up by 12.5% on the corresponding quarter of the previous year, mainly due to increased student numbers, and central government subsidies for “Lärarlönelyftet”, and amounted to MSEK 541.4 (481.5) · The number of students in the Swedish operation at the end of the quarter was 21 420 (19 795) · There were around 144,000 registrations on waiting lists at the end of the quarter, an increase of some 17,000 registrations, (13%) compared to the corresponding period in the previous year · Operating profit (

Qliro Group issues bond

Qliro Group AB (publ) “Qliro Group” has issued a three-year senior unsecured bond in the amount of SEK 250 million. The issue proceeds will be used to accelerate the development in Qliro Financial Services and other general corporate purposes.Qliro Group has issued a senior unsecured bond of SEK 250 million with a floating rate coupon of 3 month Stibor + 4.80 percent and a final maturity in May 2020. The total framework amounts to SEK 500 million and the company may look to tap the remaining bonds at a later stage. Qliro Group intends to apply for listing of the bond on Nasdaq Stockholm

Proposal of remedies to meet requirements of the EU Merger Regulation

On April 12, 2017 Nordic Capital Fund VIII, currently the indirect majority shareholder in Lindorff, notified the European Commission of the intended combination of Intrum Justitia and Lindorff. Based on its initial investigation, the European Commission has informed the parties of potential competition concerns in five Nordic/Baltic markets, relating to both debt collection and debt purchasing in each market. The parties have therefore proposed a divestment of Lindorff’s entire business in Denmark, Estonia, Finland and Sweden as well as Intrum Justitia’s entire business in Norway. In

Oncopeptides AB Interim Report January - March 2017

Stockholm, Sweden – Oncopeptides AB (Nasdaq Stockholm; ONCO) today announced the first quarter 2017 report. ”Our IPO received strong interest both from Sweden and internationally, including several well-renowned institutional long term investors. We are now fully financed to drive our broad clinical development program in late-stage multiple myeloma patients, including a phase II trial to be initiated and the ongoing phase II trials and the pivotal phase III trial OCEAN.”SUMMARY OF Q 1  January 1st – March 31st 2017 · Net sales amounted to 0.0 (0.0) MSEK · Loss for the period

Viking Line: Interim Management Statement for the period January - March 2017

Viking Line Abp            BUSINESS REVIEW         18.5.2017, 9.00 AMINTERIM MANAGEMENT STATEMENT FOR THE PERIOD JANUARY–MARCH 2017Consolidated sales of the Viking Line Group for the period January 1–March 31, 2017 were 102.1 million euros (EUR 106.9 M for January 1–March 31, 2016). Other operating revenue amounted to EUR 0.1 M (1.5). Operating income totalled EUR -17.7 M (-11.6). Net financial items totalled EUR -1.1 M (-1.5). Consolidated income before taxes amounted to EUR -18.8 M (-13.1). Income after taxes totalled EUR -15.1 M (-10.5).Competition in Viking Line’s service area

H+H International A/S - Interim financial report Q1 2017

Company Announcement No. 248, 2017 Copenhagen, Denmark, 2017-05-18 08:00 CEST (GLOBE NEWSWIRE) --   H+H International A/SDampfærgevej 3, 3rd Floor2100 Copenhagen ØDenmarkTel.: +45 35 27 02 00www.HplusH.comCompany reg. no. 49 61 98 12LEI 213800GJODT6FV8QM841         Highlights for the period 1 January to 31 March 2017 · Revenue for the first quarter of 2017 increased by 6% in local currencies (organic growth) and increased by 2% in DKK to DKK 376.5 million (2016: DKK 367.9 million). · EBITDA before special items for the first quarter of 2017 was DKK

Hexagon Composites supports Indonesia's CNG conversion ramp-up

Hexagon Composites' subsidiary Hexagon Raufoss has recently received orders from PT Autogas in Indonesia for CNG cylinders for conversion of 5,000 taxis and government vehicles to compressed natural gas (CNG). The Indonesian government is actively promoting the usage of natural gas in order to achieve their oil-to-gas program goal to reduce pollution and diversify fuel in the public transportation sector. According to new legislation that is expected to be issued by the government shortly, all gas stations will be required to have at least one dispenser of natural gas. "We are pleased

Mölnlycke opens new manufacturing plant in Havirov, Czech Republic

The opening of the new plant marks the start of Mölnlycke’s largest investment to date, EUR 67 million, and is one of the largest foreign direct investment in the country during the last years. The new plant is a milestone for the procedure tray business, and a key investment in an overall extensive global operations expansion programme by Mölnlycke. Gothenburg, Sweden – 18 May 2017  Mölnlycke, a world-leading medical products and solutions company, is pleased to announce yesterday’s opening of a new manufacturing plant in Havirov, Czech Republic. The new plant is Mölnlycke’s

A good start to the year with significant growth in the project portfolio

Summary of the first quarter 2017 · Net sales increased to 136.4 MSEK (72.9). · Operating profit went down to 21.2 MSEK (28.5). · Gross margin increased to 17.4 % (17.2). · Operating margin was 15.6 % (39.1). · Profit after tax totaled 14.4 MSEK (25.0). · Earnings per share at 0.48 SEK (0.83). · Cash flow was ‑1.5 MSEK (-87.8). · Return on equity at 18.5 % (54.2). · Debt/equity ratio was 32.2 % (31.7). · Acquisition of 530 building rights in Mariehäll and Täby. · 96.7% (98.6) sales rate for homes in production. Significant events after the balance sheet

Targovax ASA: ASCO abstract released

Oslo, Norway, 18 May 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target treatment-resistant solid tumors, today announces that the abstract "A Phase I/II trial of TG01/GM-CSF and gemcitabine as adjuvant therapy for treating patients with resected RAS-mutant adenocarcinoma of the pancreas" will be presented at the American Society of Clinical Oncology Annual Meeting 2017 (ASCO). The abstract includes clinical data from the phase I/II clinical trial evaluating TG01 in resected pancreatic cancer and

SSM begins sale of 183 attractive cooperative apartments close to the city and nature in Väsjön, Sollentuna

This week, SSM will start selling 183 attractive and space-efficient cooperative apartments in the growing urban area close to nature near Väsjön in Sollentuna. The project, which is called Sollentuna Hills, comprises apartments with a balcony/French balcony or private patio. Within the framework of the project, there are also plans for modern common spaces in the form of a lush courtyard with an outdoor spa, lounge area and barbecue facilities as well as a car and bike pool with a bike workshop. Occupation is planned for 2022.SSM, Stockholm’s leading residential developer within its niche,

FMR LLC's holdings in Tikkurila fell below 9.99 percent of shares (Announcement pursuant to the Securities Markets Act, Chapter 9, Section 5)

Tikkurila OyjStock Exchange ReleaseMay 18, 2017 at 8:00 a.m. (CET+1) FMR LLC's holdings in Tikkurila fell below 9.99 percent of shares (Announcement pursuant to the Securities Markets Act, Chapter 9, Section 5) Tikkurila Oyj (business ID 0197067-4) has received a notification, based on the Securities Markets Act, from FMR LLC on May 17, 2017. The holding of the entities controlled by FMR LLC in shares of Tikkurila Oyj fell below the 1/10 (10%) threshold due to trades executed on May 16, 2017. The holding of the above mentioned entities in Tikkurila Oyj will amount to a total of

Vietnamese ERP implementation company PNT Business Consulting Co. Ltd. joins IFS Partner Network as a reseller

Experienced Vietnamese ERP implementation company to resell IFS Applications IFS , the global enterprise applications company, has signed an agreement with PNT Business Consulting Co. Ltd. , a fast-growing ERP implementation company, to resell IFS Applications™  in Vietnam.PNT will work with IFS to build a strong customer base in the manufacturing, hi-tech and construction industries, where they will add value to emerging and expanding companies looking

Celcom teams up with Ericsson to deliver Malaysia's first 5G trial

Celcom Axiata Berhad and Ericsson have performed Malaysia's first ever 5G trial, pioneering the evolution of the nation's telecommunications technology. It is also the first 5G trial conducted on the 28GHz band in South East Asia. The trial demonstrated Celcom's commitment to bringing the best of technologies to Malaysia. The trial featured 5G Radio Prototypes, achieving a peak throughput up to 18Gbps (Gigabits per second) and latency as low as 3ms (milliseconds). It also demonstrated futuristic 5G use cases such as robotic control, connected environment, virtual reality, Internet of

Spelman College Names Co-Valedictorians for Class of 2017

ATLANTA (May 17, 2017) – Muhire Kwizera, C’2017, a mathematics major, and K’yal Bannister, C’2017, a chemistry and dual degree engineering major, have been named co-valedictorians for the Spelman College class of 2017. The seniors, each with a 4.0 G.P.A, will lead their class, comprised of 490 graduates, during the College’s 130th Commencement on Sunday, May 21, 2017, at 3 p.m. at the Georgia International Convention Center in Atlanta. Following graduation, Bannister, a native of Bushnell, Florida, will go on to earn a bachelor’s degree in chemical engineering at the California Institute

CH&LA Members Honored at National AH&LA Stars of the Industry Awards

On Wednesday, May 17th, the American Hotel & Lodging Association (AH&LA) announced the winners of the AH&LA Stars of the Industry Awards for outstanding hotel employees and properties. Two California nominees were awarded with AH&LA Stars of the Industry Awards. Awarded annually since 1966, these awards distinguish individual hotels that have developed outstanding programs, events, and campaigns and employees for their outstanding accomplishments, service, and leadership in the hospitality and lodging industry. CH&LA member winners were chosen in the categories of outstanding general

The efficacy of chemotherapy with epirubicin, one the of most used drugs in Breast Cancer can now be predicted by DRP – data published at ASCO

Hoersholm, Denmark, May 17th, 2017 – Oncology Venture Sweden AB (“Oncology Venture”) today announced that the previously warranted abstract with DRP data for epirubicin for breast cancer has been published electronically on the website of ASCO (American Society of Clinical Oncology). The title of the abstract is “Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort”.  The DRP was significantly associated to Progression Free Survival (PFS) in a cohort of 137

I AM JAZZ Community Book Reading & Discussion to be held at West Boulevard Library Branch May 18

The critically acclaimed book, I Am Jazz  — a children’s picture book by transgender teen and HRC Foundation Youth Ambassador Jazz Jennings and co-author, Jessica Herthel — was written to help people of all ages gain an understanding of transgender youth.  On May 18, from 4 to 5 p.m., the Charlotte Mecklenburg Library’s West Boulevard Library location (2157 West Boulevard, Charlotte, NC) will host a reading of I Am Jazz . Following the reading, members

Sony Introduces Two New Wide-Angle Full-Frame E-Mount Lenses

New 16-35mm F2.8 GM Completes the E-mount F2.8 G Master “trinity”; 12-24mm F4 G covers widest angle among all full-frame E-mount lensesTORONTO, May 17, 2017 – Sony, a worldwide leader in digital imaging and the world’s largest image sensor manufacturer, has today announced two new additions to their growing lineup of full-frame E-mount lenses.   The new lenses include the FE 16-35mm F2.8 GM large aperture wide-angle zoom lens (model SEL1635GM) and the FE 12-24mm F4 G ultra-wide-angle zoom lens (model SEL1224G).  The FE 16-35mm F2.8 GM lens brings the incredible high-resolution and

There are no items matching the current filter
There are no more items matching the current filter
Back to top